Conventional organic dyes and inorganic fluorescent contrast agents have been obstructed in bioimaging and biomedical applications, because of their intrinsic drawbacks including toxicity and poor biocompatibility. Thus, there is a pressing need to develop innovative classes of nanomaterials and fluorescent contrast agents with merits of high photostability, remarkable safety, and significant biocompatibility for biomedical and clinical applications. In this critical review, recent trends and future prospects regarding the eco-friendly and sustainable synthesis of biocompatible nanomaterials for diagnosis/imaging, bioimaging and cellular imaging are discussed as well as important challenges for sophisticated sensitive and noninvasive clinical diagnostic imaging. Particularly, the potential of biocompatible nanocontrast agents is discussed for further improvements of magnetic resonance imaging (MRI) and computed tomography (CT) scanning performance, remarkably for cancer diagnosis/imaging and therapy. However, it appears that further investigations and comprehensive evaluations should be accomplished to find innovative strategies and relevant challenges in this important field of science.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据